Lanjun Li

机构：First Affiliated Hospital of Zhengzhou University · ORCID：0000-0001-7660-3500

发表论文 29 篇 · 总被引 295 次 · h-index 10

代表论文

Mitochondrial uncoupler BAM15 inhibits artery constriction and potently activates AMPK in vascular smooth muscle cells (2018 · Acta Pharmaceutica Sinica B · 被引 35)
Optimization of the Detection Method for Phosphorylated α-Synuclein in Parkinson Disease by Skin Biopsy (2020 · Frontiers in Neurology · 被引 32)
Neutrophil Percentage-to-Albumin Ratio: A Good Parameter for the Evaluation of the Severity of Anti-NMDAR Encephalitis at Admission and Prediction of Short-Term Prognosis (2022 · Frontiers in Immunology · 被引 28)
Injectable pegylated niclosamide (polyethylene glycol‐modified niclosamide) for cancer therapy (2019 · Journal of Biomedical Materials Research Part A · 被引 28)
Peripheral synucleinopathy in Parkinson disease with LRRK2 G2385R variants (2021 · Annals of Clinical and Translational Neurology · 被引 24)
FcRn inhibitors: Transformative advances and significant impacts on IgG-mediated autoimmune diseases (2024 · Autoimmunity Reviews · 被引 19)